The High-Stakes Battle Over The Future Of Mass Psychedelics
March 25, 2026
Legislators advance two different psychedelic therapy bills, will consider landmark programs for ibogaine and psilocybin
Legislators advance two different psychedelic therapy bills, will consider landmark programs for ibogaine and psilocybin
The legislation is unique from other measures in consideration for its broad scope, including ibogaine and MDMA
“We knew we wanted to do something in psychedelics as we believed [Amanita muscaria] could be disruptive to the existing medicinal landscape.”
